Event time: 事件时间：
Published: 文章发布：
UBS, Neutral Rating Maintained raises INCY target to $127UBS, Neutral Rating Maintained 上调目标价 因塞特医疗 (INCY) 至 $127
On 2026-10-05, UBS, Neutral Rating Maintained raised its INCY price target to $127.
UBS, Neutral Rating Maintained 于 2026-10-05 将 INCY 目标价上调至 $127。
For information only. Not investment advice.内容仅供参考，不构成投资建议。